VDAC3 and amyotrophic lateral sclerosis: Specifically, the post-translational modifications identified and discussed here may represent sufficient conditions to alter the physiological pool of interactors of VDAC3 and modify its specific ability to buffer ROS, possibly impacting IMM redox signaling in ALS.